Carl H June Selected Research

Highly Active Antiretroviral Therapy (HAART)

1/2016	A Cure for HIV Infection: "Not in My Lifetime" or "Just Around the Corner"?
3/2014	Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.
6/2002	A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carl H June Research Topics

Disease

180	Neoplasms (Cancer) 05/2024 - 02/2002
31	Hematologic Neoplasms (Hematological Malignancy) 02/2024 - 11/2006
29	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2024 - 04/2013
24	Leukemia 01/2023 - 03/2008
20	Cytokine Release Syndrome 02/2024 - 04/2013
16	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2024 - 08/2011
15	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 04/2003
13	Lymphoma (Lymphomas) 05/2024 - 03/2008
13	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017 - 12/2004
11	Multiple Myeloma 08/2023 - 01/2011
11	Infections 01/2021 - 01/2002
10	HIV Infections (HIV Infection) 01/2016 - 01/2002
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 10/2009
7	Breast Neoplasms (Breast Cancer) 01/2023 - 03/2005
7	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 02/2015
5	Adenocarcinoma 01/2023 - 01/2016
5	Melanoma (Melanoma, Malignant) 01/2023 - 05/2003
5	Carcinoma (Carcinomatosis) 11/2019 - 03/2005
5	Communicable Diseases (Infectious Diseases) 01/2019 - 02/2002
4	Bites and Stings (Sting) 05/2024 - 01/2017
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2024 - 12/2017
4	Persistent Infection 07/2023 - 02/2007
4	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 01/2018
4	Neuroblastoma 09/2020 - 12/2012
4	Inflammation (Inflammations) 01/2019 - 10/2009
4	Testicular Neoplasms (Testicular Cancer) 01/2016 - 04/2013
4	Mesothelioma 06/2013 - 03/2005
3	cell-associated neurotoxicity 03/2024 - 01/2022
3	Residual Neoplasm 02/2024 - 01/2023
3	Fibrosis (Cirrhosis) 07/2023 - 01/2019
3	Sepsis (Septicemia) 01/2022 - 11/2019
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2018
3	Critical Illness (Critically Ill) 10/2020 - 01/2016
3	Malignant Mesothelioma 11/2019 - 04/2010
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2018 - 12/2017
3	Body Weight (Weight, Body) 10/2014 - 08/2011
3	Lymphopenia (Lymphocytopenia) 12/2012 - 11/2005
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2024 - 01/2023
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023 - 01/2023
2	Autoimmune Diseases (Autoimmune Disease) 11/2022 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2018
2	COVID-19 01/2022 - 01/2020
2	Brain Neoplasms (Brain Tumor) 01/2019 - 07/2017
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2018 - 12/2017
2	Disease Progression 11/2018 - 01/2002
2	Hodgkin Disease (Hodgkin's Disease) 01/2018 - 10/2017

Drug/Important Bio-Agent (IBA)

136	Chimeric Antigen ReceptorsIBA 05/2024 - 03/2008
48	AntigensIBA 01/2024 - 11/2002
27	CytokinesIBA 05/2024 - 01/2002
20	tisagenlecleucelIBA 02/2024 - 04/2013
18	MesothelinIBA 08/2023 - 03/2009
14	Proteins (Proteins, Gene)FDA Link 08/2023 - 11/2002
11	Neoplasm Antigens (Tumor Antigens)IBA 08/2023 - 01/2003
10	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 08/2011
9	VaccinesIBA 10/2023 - 06/2007
8	Messenger RNA (mRNA)IBA 02/2024 - 11/2010
8	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2024 - 04/2013
8	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2010
6	EnzymesIBA 08/2023 - 11/2002
6	epidermal growth factor receptor VIIIIBA 01/2021 - 01/2013
6	AntibodiesIBA 10/2020 - 01/2013
6	Interleukin-2 (IL2)IBA 01/2018 - 01/2005
5	Interleukin-18 (Interleukin 18)IBA 05/2024 - 09/2008
5	InterferonsIBA 05/2024 - 11/2002
5	EpitopesIBA 10/2023 - 06/2012
5	B-Cell Maturation AntigenIBA 08/2023 - 01/2019
5	Peptides (Polypeptides)IBA 01/2021 - 01/2003
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2019 - 05/2012
5	tocilizumab (atlizumab)FDA Link 01/2019 - 04/2013
4	ibrutinibIBA 11/2022 - 01/2016
4	Antiviral Agents (Antivirals)IBA 01/2022 - 11/2006
4	ChemokinesIBA 01/2022 - 06/2015
4	Sirolimus (Rapamycin)FDA Link 10/2015 - 08/2008
3	Monoclonal AntibodiesIBA 01/2023 - 10/2010
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2016
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 03/2005
3	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 01/2002
3	Melphalan (Alkeran)FDA LinkGeneric 01/2019 - 09/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2017 - 08/2015
3	Surface Antigens (Surface Antigen)IBA 01/2016 - 01/2014
3	Chemokine ReceptorsIBA 06/2015 - 07/2011
2	ErbB Receptors (EGF Receptor)IBA 02/2024 - 01/2021
2	Vancomycin FDA LinkGeneric 01/2023 - 01/2018
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022 - 11/2006
2	Single-Domain AntibodiesIBA 11/2021 - 01/2020
2	blinatumomabIBA 11/2019 - 10/2016
2	Immune Checkpoint InhibitorsIBA 01/2019 - 12/2018
2	CTL019 chimeric antigen receptorIBA 12/2018 - 04/2013
2	Bevacizumab (Avastin)FDA Link 11/2018 - 01/2013
2	AutoantigensIBA 01/2018 - 01/2016

Therapy/Procedure

117	Therapeutics 05/2024 - 01/2002
80	Immunotherapy 02/2024 - 02/2002
17	Drug Therapy (Chemotherapy) 01/2023 - 01/2002
9	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2010
8	Stem Cell Transplantation 01/2019 - 02/2006
5	Hematopoietic Stem Cell Transplantation 01/2017 - 06/2010
4	Transplantation 12/2017 - 01/2011
3	Highly Active Antiretroviral Therapy (HAART) 01/2016 - 06/2002
3	Cell Transplantation 04/2013 - 09/2003
2	Radiotherapy 01/2018 - 07/2013